Search research articles
Contact Us
Filters
Showing results (1-10 of 510) with videos related to
Page
of 51
Sort By:
Journal of Medical Economics
|
August 27, 2015
The need for cost-effective choices to treat patients with bipolar 1 disorders including asenapine
Brian Godman
The Lancet. Infectious Diseases
|
October 8, 2019
Implications of non-prescription antibiotic sales in China
Aubrey Kalungia, Brian Godman
Current Medical Research and Opinion
|
July 21, 2017
Non-guideline-recommended prescribing of proton pump inhibitors: implications for the future and reducing over usage
Brian Godman, Joseph Fadare
Journal of Medical Economics
|
November 19, 2020
Key patient related factors in the management of inflammatory bowel disease
Eleonora Allocati, Brian Godman
BMC Health Services Research
|
April 16, 2016
Do newly marketed generic medicines expand markets using descriptive time series analysis and mixed logit models? Korea as an exemplar and its implications
Hye-Young Kwon, Brian Godman
Applied Health Economics and Health Policy
|
January 17, 2013
A new reimbursement system for innovative pharmaceuticals combining value-based and free market pricing
Brian Godman, Lars L Gustafsson
Applied Health Economics and Health Policy
|
February 1, 2017
Drug Pricing in South Korea
Hye-Young Kwon, Brian Godman
BMC Health Services Research
|
March 17, 2017
Erratum to: Do newly marketed generic medicines expand markets using descriptive time series analysis and mixed logit models? Korea as an exemplar and its implications
Hye-Young Kwon, Brian Godman
Frontiers in Pharmacology
|
March 3, 2023
Editorial: Pharmaceutical policy, impact and health outcomes
Hye-Young Kwon, Brian Godman
Expert Review of Anti-Infective Therapy
|
April 18, 2026
Non-prescription antibiotic dispensing and counselling practices in Iraqi community pharmacies: implications for Antimicrobial stewardship and resistance containment
Omeed Darweesh, Brian Godman, Amanj Kurdi
Page
of 51
Search research articles
Search
Showing results (1-10 of 510) with videos related to
Sort By:
Page
of 51
Journal of Medical Economics
|
August 27, 2015
The need for cost-effective choices to treat patients with bipolar 1 disorders including asenapine
Brian Godman
The Lancet. Infectious Diseases
|
October 8, 2019
Implications of non-prescription antibiotic sales in China
Aubrey Kalungia, Brian Godman
Current Medical Research and Opinion
|
July 21, 2017
Non-guideline-recommended prescribing of proton pump inhibitors: implications for the future and reducing over usage
Brian Godman, Joseph Fadare
Journal of Medical Economics
|
November 19, 2020
Key patient related factors in the management of inflammatory bowel disease
Eleonora Allocati, Brian Godman
BMC Health Services Research
|
April 16, 2016
Do newly marketed generic medicines expand markets using descriptive time series analysis and mixed logit models? Korea as an exemplar and its implications
Hye-Young Kwon, Brian Godman
Applied Health Economics and Health Policy
|
January 17, 2013
A new reimbursement system for innovative pharmaceuticals combining value-based and free market pricing
Brian Godman, Lars L Gustafsson
Applied Health Economics and Health Policy
|
February 1, 2017
Drug Pricing in South Korea
Hye-Young Kwon, Brian Godman
BMC Health Services Research
|
March 17, 2017
Erratum to: Do newly marketed generic medicines expand markets using descriptive time series analysis and mixed logit models? Korea as an exemplar and its implications
Hye-Young Kwon, Brian Godman
Frontiers in Pharmacology
|
March 3, 2023
Editorial: Pharmaceutical policy, impact and health outcomes
Hye-Young Kwon, Brian Godman
Expert Review of Anti-Infective Therapy
|
April 18, 2026
Non-prescription antibiotic dispensing and counselling practices in Iraqi community pharmacies: implications for Antimicrobial stewardship and resistance containment
Omeed Darweesh, Brian Godman, Amanj Kurdi
Page
of 51